Keyphrases
Surgical Patients
100%
Intensive Care Unit Patients
100%
Confidence Interval
67%
Intensive Care Unit
66%
Meta-analysis
50%
Operative
50%
Randomized Clinical Trial
50%
Intravenous Fluids
50%
Furosemide
50%
Systematic Meta-analysis
50%
Septic Shock
50%
Carbohydrates
50%
Delirium
50%
Haloperidol
50%
Cerebral Oxygenation
50%
Endotracheal Intubation
50%
Restrictive Fluid
33%
Risk Ratio
31%
Placebo Groups
25%
Number of Days
23%
Absolute Difference
21%
Recovery Room
21%
Anesthesia
21%
Intravenous Fluid Therapy
16%
Placebo
15%
Preparation for Surgery
14%
Lactate
14%
Adult Patients
13%
Clinical Analysis
12%
Acute Kidney Injury
12%
Volume of Fluid
8%
Fluid Restriction
8%
Shock
8%
Days Alive without Life Support
8%
Randomized Trial
8%
Serious Adverse Events
8%
Novo Nordisk
8%
Tracheal Surgery
7%
Intravenous Anesthesia
7%
Open Aortic Surgery
7%
Infiltration
7%
Internal Jugular Venous
7%
Sensory Blockade
7%
Aortic Surgery
7%
Brain Activation
7%
Anesthesia Induction
7%
Thoracic Epidural Anesthesia
7%
Endovascular Procedures
7%
Concentration Difference
7%
Bupivacaine
7%
Medicine and Dentistry
Furosemide
50%
Meta-Analysis
50%
Systematic Review
50%
Infusion Fluid
50%
Septic Shock
50%
Intensive Care Unit
50%
Randomized Clinical Trial
50%
Tracheal Intubation
50%
Post-Anesthesia Care Unit
37%
Lactic Acid
25%
Aortic Surgery
25%
Intravenous Drug Administration
16%
Sequential Analysis
12%
Trachea Surgery
12%
Intravenous Anesthesia
12%
Acute Kidney Injury
12%
Induction of Anesthesia
12%
Thorax Epidural Anesthesia
12%
Endovascular Surgery
12%
Bupivacaine
12%
Adverse Event
8%
Shock (Circulatory)
8%
Postoperative Care
6%
Postoperative Period
6%
Hypertensive Factor
6%
Systematic Review with Meta-Analysis
6%
All Cause Mortality
6%
Diuretic Agent
6%
Renal Replacement Therapy
6%
Oliguria
6%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
50%
Infusion Fluid
50%
Furosemide
50%
Septic Shock
50%
Delirium
50%
Randomized Clinical Trial
50%
Placebo
45%
Acute Kidney Failure
12%
Adverse Event
11%
All Cause Mortality
6%
Diuretic Agent
6%
Hypertensive Factor
6%
Oliguria
6%
Replacement Therapy
6%
Recurrent Disease
5%
Acute Disease
5%
